Palatin Technologies
PTN
#10103
Rank
ยฃ26.41 M
Marketcap
ยฃ14.90
Share price
0.10%
Change (1 day)
8,890.30%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -ยฃ3.81 Million

According to Palatin Technologies's latest financial reports the company's current earnings are ยฃ8.84 Million. In 2024 the company made an earning of -ยฃ19.85 Million, an increase over its 2023 earnings that were of -ยฃ23.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ3.81 Million-80.82%
2024 -ยฃ19.85 Million-16.9%
2023 -ยฃ23.88 Million5.99%
2022 -ยฃ22.54 Million-13.7%
2021 -ยฃ26.11 Million33.25%
2020 -ยฃ19.6 Million-172.11%
2019 ยฃ27.17 M2352.33%
2018 ยฃ1.1 M-94.13%
2017 ยฃ18.87 M-154.92%
2016 -ยฃ34.38 Million3.67%
2015 -ยฃ33.16 Million878%
2014 -ยฃ3.4 Million-72.64%
2013 -ยฃ12.4 Million-33.11%
2012 -ยฃ18.53 Million77.71%
2011 -ยฃ10.43 Million
2003 -ยฃ17.66 Million29.93%
2002 -ยฃ13.59 Million36.18%
2001 -ยฃ9.98 Million
1999 -ยฃ8.29 Million6.04%
1998 -ยฃ7.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.71 B-699,817.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ10.39 B-294,318.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ0.46 B-13,374.02%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-ยฃ8.85 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.12 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ86.67 Million 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ70.56 M-2,097.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-ยฃ21.73 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-ยฃ44.67 Million 1,164.42%๐Ÿ‡บ๐Ÿ‡ธ USA